| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $179.1M | — | — |
| R&D Expense | $4.1M | — | -54.0% |
| SG&A Expense | $5.9M | — | +1.0% |
| Operating Income | $168.9M | — | +757.3% |
| Income Tax | $0 | — | — |
| Net Income | $169.7M | — | +791.9% |
| EPS (Basic) | $0.88 | — | +776.9% |
| EPS (Diluted) | $0.87 | — | +769.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $23.7M | +31.6% | -36.1% |
| Accounts Receivable | $1.3M | -9.3% | +11.0% |
| Current Assets | $277.0M | +193.3% | +137.2% |
| Total Assets | $277.2M | +192.9% | +136.9% |
| Current Liabilities | $5.1M | -15.0% | -73.7% |
| Long-term Debt | $0 |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$8.1M | — | +39.4% |
| Investing Cash Flow | $2.2M | — | -80.6% |
| Financing Cash Flow | $11.6M | — | +317.3% |
| — |
| Total Liabilities | $17.0M | -5.8% | -55.1% |
| Stockholders' Equity | $260.2M | +239.8% | +228.7% |